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Introduction
Gap junctions mediate intracellular signaling events, which in 
turn  regulate  various  downstream  cellular  and  physiological 
functions (Bennett and Verselis, 1992; Scemes et al., 2007). 
Gap junction proteins allow ions and small molecules to pass 
between adjacent cells via gap junctions, and between cells and 
the extracellular space via hemichannels (Unger et al., 1999; 
Bruzzone et al., 2001). In vertebrates, gap junction proteins are 
categorized  into  two  families,  connexins  (Cxs)  and  pannex-
ins (Panxs; Vinken et al., 2006). The connexin family has >20 
members and has been relatively well characterized. Dysregulation 
and mutations of connexins cause several human diseases, in-
cluding cancer, hypertension, atherosclerosis, and developmental   
abnormalities (Laird, 2006). The pannexin family is less well   
known and consists of only three members: Panx1, -2, and -3   
(Panchin et al., 2000; Baranova et al., 2004; D’hondt et al., 2009).   
Panx1 is ubiquitously expressed, especially in the central ner-
vous system. Panx2 is also expressed in the central nervous sys-
tem (Bruzzone et al., 2003). Panx3 is expressed in skin, cochlea, 
and in developing hard tissues including cartilage and bone 
(Penuela et al., 2007; Penuela et al., 2008; Wang et al., 2009; 
Iwamoto et al., 2010). Panx3 is induced in the prehypertrophic 
zone in developing growth plates, and it inhibits parathyroid 
hormone–mediated chondrocyte proliferation through its hemi-
channel activity and promotes differentiation in culture (Iwamoto 
et al., 2010). Panx3 expression is also known to inhibit pro-
liferation of keratinocytes (Celetti et al., 2010), although the 
underlying mechanism has not yet been established.
Ca
2+ is a universal intracellular signaling molecule that regu-
lates cell proliferation, differentiation, morphology, and function 
(Berridge et al., 2000b). Intracellular Ca
2+ concentration ([Ca
2+]i) 
can rise more than fivefold via Ca
2+ influx from the extracellular 
space and/or release from the ER, an intracellular Ca
2+ storage   
T
he pannexin proteins represent a new gap junction 
family. However, the cellular functions of pannex-
ins remain largely unknown. Here, we demonstrate 
that  pannexin  3  (Panx3)  promotes  differentiation  of   
osteoblasts and ex vivo growth of metatarsals. Panx3   
expression was induced during osteogenic differentiation 
of C2C12 cells and primary calvarial cells, and suppres-
sion of this endogenous expression inhibited differentia-
tion. Panx3 functioned as a unique Ca
2+ channel in the 
endoplasmic reticulum (ER), which was activated by puri-
nergic  receptor/phosphoinositide  3-kinase  (PI3K)/Akt 
signaling, followed by activation of calmodulin signaling 
for differentiation. Panx3 also formed hemichannels that 
allowed release of ATP into the extracellular space and 
activation of purinergic receptors with the subsequent   
activation  of  PI3K–Akt  signaling.  Panx3  also  formed 
gap  junctions  and  propagated  Ca
2+  waves  between 
cells. Blocking the Panx3 Ca
2+ channel and gap junction   
activities inhibited osteoblast differentiation. Thus, Panx3 
appears to be a new regulator that promotes osteoblast 
differentiation by functioning as an ER Ca
2+ channel and 
a hemichannel, and by forming gap junctions.
Pannexin 3 functions as an ER Ca
2+ channel, 
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Figure 1.  Expression of Panx3 in growth plates, C2C12 cells, and primary calvarial cells. (A) Immunostaining of newborn mouse growth plates. Image 
under light microscopy (a), Panx3 (b), Ocn (c), Hoechst nuclear staining (blue), and merged image (d). Arrowheads, perichondrium/periosteum. (B) Semi-
quantitative RT-PCR. C2C12 cells (a) and primary calvarial cells (b) were cultured with BMP2 and ascorbate, respectively, at day 0. Panx3 was induced 1259 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
during osteoblast differentiation in both cell types. Runx2, osterix, ALP, and Ocn are osteoblast differentiation marker genes. Nat1 was used as a control. 
(C, a) Cellular localization of endogenous Panx3 in undifferentiated (a–c) and differentiated C2C12 cells (d–f) after 4 d of culture with BMP2. Panx3 (red) 
was localized in the plasma membrane, cell–cell junctions, and ER membranes in differentiated cells. Calnexin was used as an ER marker. (b) Measure-
ments show a percentage of colocalization between Panx3 with calnexin (top), and calnexin with Panx3 (bottom). *, P < 0.05. Error bars represent the 
mean ± SD; n = 12.
 
organelle, when cells are activated by extracellular stimuli. Inositol 
trisphosphate 3 (IP3) receptors (IP3Rs) are ubiquitously expressed 
and act as ER Ca
2+ channels upon IP3 binding (Mikoshiba, 2007). 
IP3 synthesis for activation of IP3R ER channels can be induced 
by many stimuli. For example, external ATP can bind purinergic 
receptors (P2Rs) in the plasma membrane, and this triggers acti-
vation of phospholipase C (PLC) and subsequent IP3 generation. 
Ryanodine receptors (RyRs) are also known to function as ER Ca
2+ 
channels in some tissues (Fill and Copello, 2002). More recently, 
Panx1 was unexpectedly found to function as an ER Ca
2+ channel 
in prostate cancer cells (Vanden Abeele et al., 2006).
The Ca
2+ binding protein calmodulin (CaM) is one of the 
major Ca
2+ signaling mediators (Berridge et al., 2000b), and the 
CaM pathway regulates osteoblast differentiation (Zayzafoon, 
2006). Osteoblasts differentiate from mesenchymal stem cells 
and form bone through endochondral and intramembranous   
ossification. Growth factors such as BMP2 induce the master   
osteogenic proteins Runx2 and osterix (Osx/Sp7). This leads 
to the activation of osteogenic marker genes, and subsequently, 
to  terminal  differentiation  of  osteoblasts  (Fujita  et  al.,  2004; 
Mukherjee and Rotwein, 2009). Many signaling molecules have 
been identified that positively or negatively regulate osteoblast 
differentiation. For example, phosphoinositide 3-kinase (PI3K)/
Akt signaling is crucial for osteoblast differentiation (Fujita et al., 
2004; Mukherjee and Rotwein, 2009), whereas p53 is a negative 
regulator for osteogenesis (Wang et al., 2006). In the case of CaM, 
binding to Ca
2+ activates downstream signaling molecules such as 
CaM kinase II (CaMKII) and calcineurin (CN), and promotes   
osteoblast differentiation (Zayzafoon et al., 2005).
Our previous study showed that Panx3 mRNA is expressed 
in osteoprogenitors and osteoblasts, and prompted us to explore in 
more detail the role of Panx3 in osteoblast differentiation. In the 
present study, we demonstrate that Panx3 is induced during osteo-
blast differentiation and promotes differentiation. We found that 
Panx3 functions as an ER Ca
2+ channel and is regulated through 
a PI3K–Akt pathway. The Panx3 Ca
2+ ER channels regulate CaM 
pathways and promote osteogenic differentiation. Panx3, acting 
as a hemichannel, also promotes the release of ATP into the extra-
cellular space. The released ATP may bind to P2Rs followed by 
activation of PI3K–Akt signaling. Furthermore, Panx3 gap junc-
tions propagate a Ca
2+ wave between cells and enhance osteoblast 
differentiation. Our results reveal that Panx3 plays a multifunc-
tional role as a new regulator of osteoblast differentiation.
Results
Panx3 expression and localization  
in growth plates and  
differentiating osteoblasts
We previously reported that Panx3 mRNA is expressed in pre-
hypertrophic chondrocytes, in the perichondrium/periosteum, 
and in osteoblasts in the growth plate (Iwamoto et al., 2010). 
Immunohistochemistry showed that the Panx3 protein was ex-
pressed in prehypertrophic and hypertrophic chondrocytes, as 
well as in the perichondrium/periosteum, which are progenitors 
for osteoblasts (arrowheads in Fig. 1 A, b). Immunostaining of 
osteocalcin  (Ocn),  an  osteoblast  marker,  showed  a  distinct 
boundary between cartilage and bone. Panx3 was also expressed 
in osteoblasts (Fig. 1 A, c and d).
To study the role of Panx3 in osteoblast differentiation, we 
analyzed the expression of Panx3 mRNA in the osteoprogenitor 
cell line C2C12, and in primary calvarial cells from newborn 
mice (Fig. 1 B). Panx3 mRNA was not detectable in undif-
ferentiated cells. However, when the cells differentiated into   
osteoblasts, Panx3 expression was found concomitantly with the 
induction of osteoblast marker genes such as Runx2, osterix, 
alkaline phosphatase (ALP), and Ocn (Fig. 1 B, a and b). Simi-
lar induction of Panx3 mRNA expression was observed during 
osteogenic differentiation of MC3T3-E1 and C3H10T1/2 cells 
(unpublished data).
We next examined subcellular localization of the Panx3 
protein in C2C12 cells using fluorescence confocal microscopy 
(Fig. 1 C). In differentiating C2C12 cells, Panx3 was localized 
to the plasma membrane and within cell–cell contact areas, as 
well as diffusely in the cytosol. Calnexin, an ER marker, was 
colocalized with Panx3, which suggests that Panx3 is localized 
in the ER (Fig. 1 C, f). Quantitative analysis revealed that 60% 
of the Panx3 protein was colocalized with calnexin, whereas 
90% of calnexin was colocalized with Panx3 (Fig. 1 C, b). 
These results suggest that Panx3 may function at multiple sub-
cellular regions.
Panx3 promotes osteoblast differentiation
For further elucidation of the Panx3 function during osteoblast 
differentiation, we examined whether Panx3 expression pro-
motes osteogenic differentiation of C2C12 cells. After transfec-
tion with the Panx3 expression vector (pEF1/Panx3; Fig. S1,   
A and B), C2C12 cells were induced to differentiate, and mRNA 
expression of osteoblast marker genes was analyzed over time 
using real-time quantitative PCR (Fig. 2 A). The expression of 
osterix, ALP, and Ocn was increased in Panx3-overexpressing 
cells compared with control cells transfected with vector pEF1, 
whereas the Runx2 expression level was unaffected in both cell 
types (Fig. 2 A). When endogenous Panx3 expression was in-
hibited by shPanx3 RNA transfection (Fig. S1, A and B), the 
induction levels of the osterix, ALP, and Ocn, but not of Runx2, 
were reduced (Fig. 2 B). Panx3 overexpression also promoted 
ALP  activity  and  mineralization,  whereas  suppression  of  en-
dogenous Panx3 by shPanx3 inhibited these processes (Fig. 2,   
C and D). We observed similar results in primary calvarial cells 
(Fig. S2, A, B, and C). Collectively, these findings indicated that 
Panx3 promotes osteoblast differentiation processes.JCB • VOLUME 193 • NUMBER 7 • 2011   1260
Figure 2.  Panx3 promotes osteoblast differentiation. C2C12 cells were transiently transfected with a control pEF1 vector, pEF1/Panx3, a control sh 
vector, or a Panx3 shRNA vector, and these cells were cultured with BMP2 for various durations, as indicated. Total RNA was extracted each day for 4 d 
and mRNA levels were analyzed by quantitative RT-PCR. (A) Panx3 overexpression promoted the expression of osteoblast marker genes for osterix, ALP, 
and Ocn, except that the expression of Runx2 remained the same. (B) shPanx3 suppressed the induction of these genes, except for Runx2. (C) Panx3 1261 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
overexpression promoted ALP activity, whereas shPanx3 inhibited it. Representative ALP staining (top) and its quantitative data (bottom). C2C12 cells and 
pEF1/Panx3- and shPanx3-transfected C2C12 cells were cultured with BMP2 for 3 d. (D) Representative Alizarin red S staining (top) and its quantitative 
data (bottom) of C2C12 and pEF1/panx3- and shPanx3-transfected C2C12 cells cultured with BMP2 for 15 d. **, P < 0.01. Error bars represent the 
mean ± SD; n = 3.
 
Panx3 promotes metatarsal bone growth
Because Panx3 was expressed in the perichondrium/periosteum 
and osteoblasts, we analyzed Panx3 functions further with re-
spect to ex vivo growth of the metatarsus. Metatarsal bones 
from newborn mice were cultured and infected with Panx3 ex-
pression adenovirus (AdPanx3). AdPanx3 promoted growth 
in the length and width of both cartilage and bone in meta-
tarsus after 3 d in culture compared with the growth in the 
control adenovirus-infected metatarsus, as shown in videos 
and histology sections (Fig. 3 A, a; Fig. 3 B, a and b; and 
Videos 1 and 2). AdPanx3 infection increased not only the 
expression of Panx3, but also the expression of the osteoblast 
marker genes osterix, ALP, and Ocn (Fig. 3 C). To inhibit endog-
enous Panx3 activity, we used an inhibitory Panx3 peptide 
from the extracellular domain of Panx3, which blocked hemi-
channel activity and the release of ATP release (see Fig. 6), as 
described previously (Iwamoto et al., 2010). Addition of the 
Panx3 peptide to a metatarsus culture inhibited the growth 
in length and width compared with the growth without the 
peptide or growth in a culture with a control scrambled pep-
tide (Figs. 3 A, b; Fig. 3 B, a and b; and Videos 3 and 4). The 
Panx3 peptide inhibited the expression of osteoblast marker 
genes (Fig. 3 C), which indicates that Panx3 regulates growth 
plate expansion.
Panx3 functions as an ER Ca
2+ channel
Because the intracellular Ca
2+ level ([Ca2
+]i) plays an important 
role in osteoblast differentiation (Zayzafoon et al., 2005; Seo   
et al., 2009), we examined whether intracellular Ca
2+ signaling is 
involved in Panx3-promoted osteoblast differentiation. The ER 
serves as the main intracellular Ca
2+ storage compartment. In the 
ER membrane, the sarco/endoplasmic reticulum Ca
2+-ATPase 
(SERCA) takes up Ca
2+ from the cytosol to the ER, whereas 
the ubiquitous IP3 receptors (IP3R1, -2, and -3), as well as the 
RyRs in certain cell types, serve as ER Ca
2+ channels for Ca
2+ 
release from the ER (Keller and Grover, 2000; Fill and Copello, 
2002; Futatsugi et al., 2005). Extracellular ATP can bind to   
purinergic receptors (P2Rs) and subsequently activate down-
stream intracellular signaling cascades. These signaling path-
ways are known to promote IP3 production, thereby activating 
IP3R ER Ca
2+ channels and increasing [Ca
2+]i (Solini et al., 2008). 
In C2C12 cells, all IP3Rs are expressed, with IP3R3 showing 
the highest expression level (Powell et al., 2001), whereas RyRs 
are not expressed (Fig. S1 C; Biswas et al., 1999). No significant 
change was observed in the expression levels of IP3Rs during 
osteogenic differentiation of C2C12 (Fig. S1 C). Because Panx3 
was induced during differentiation of C2C12 and calvarial cells 
and was localized in the ER, Panx3 may function as an ER Ca
2+ 
channel, thereby increasing [Ca
2+]i and subsequently promoting 
osteoblast differentiation. To explore Panx3 Ca
2+ ER channel 
activity, Panx3 overexpressing C2C12 and calvarial cells were 
loaded with a UV-excitable intracellular Ca
2+ indicator, Fura-2 
AM, in Ca
2+-free media. The cells were then stimulated by ATP, 
and increases in the [Ca
2+]i level were measured over a time 
course and compared with [Ca
2+]i levels in control cells lack-
ing Panx3 (Fig. 4 A, a and b). [Ca
2+]i was approximately two-
fold higher in Panx3-overexpressing C2C12 and calvarial cells 
than in control cells. This suggests that Panx3 may act as an ER   
Ca
2+ channel.
To  measure  steady-state  [Ca
2+]i  levels  during  differen-
tiation, C2C12 cells were cultured with BMP2, and [Ca
2+]i was   
analyzed without ATP stimulation (Fig. 4 A, c). The level of [Ca
2+]i 
in undifferentiated C2C12 cells was 100 nM, a concentration 
typically observed in cells at rest. At 5 d after differentiation by 
BMP2, [Ca
2+]i was increased to 180 nM, and this [Ca
2+]i in-
crease was further enhanced to 225 nM in Panx3-overexpressing 
C2C12 cells. Inhibition of differentiation by shPanx3 reduced 
[Ca
2+]i. Collectively, these results suggest that Panx3 regulates 
[Ca
2+]i. Similar [Ca
2+]i increases in calvarial cells were observed 
during osteogenic differentiation (Fig. S2 D).
Panx3 activates the CaM pathways  
for differentiation
Intracellular Ca
2+ activates and affects many signaling pathways 
that modulate cell differentiation (Berridge et al., 2000a). Upon 
Ca
2+ binding, CaM activates many downstream signaling mol-
ecules such as CaMKII and the phosphatase CN, and promotes 
osteoblast differentiation (Berridge et al., 2000b; Seo et al., 
2009). NFATc1 is activated through dephosphorylation by CN   
and can promote expression of genes such as osterix, a key mole-
cule involved in osteogenesis (Beals et al., 1997; Nakashima et al., 
2002; Koga et al., 2005; Zayzafoon, 2006). We first examined 
the CaMKII–CN signaling pathways in pEF1/Panx3-transfected 
C2C12 (Fig. 4 B) and calvarial cells (Fig. 4 C) after short osteo-
genic induction. Although the CaM protein level remained the   
same, we found that CaM activity was induced, which resulted 
in an increase in the phosphorylation of CaMKII in pEF1/Panx3-
transfected cells (Fig. 4, B and C). It also increased the phospha-
tase activity and protein levels of CN, resulting in an increase 
in the level of dephosphorylated NFATc1 (active form) as well 
as the NFATc1 protein levels in both cell types compared with 
control cells. The increase in NFATc1 protein levels is likely 
caused  by  the  enhanced  NFATc1  transcription  levels  in  the 
CaMKII–c-fos pathway (Koga et al., 2005; Zayzafoon et al.,   
2005). In a subsequent experiment involving the inhibition of 
endogenous Panx3 expression, shPanx3- and shControl-transfected 
cells were cultured under induction conditions for 1 d to induce   
endogenous Panx3, and the activation of these factors was mea-
sured. Inhibition with shPanx3 reduced the phosphorylation levels 
of CaMKII and increased inactive phosphorylated NFATc1 levels 
in C2C12 cells and to a lesser extent in calvarial cells (Fig. 4,   
B and C). The effects of Panx3 on the CaM pathways were less 
prominent in calvarial cells than in C2C12 cells, likely because 
of  differences  in  their  transfection  efficiency.  pEF1/Paxn3  and JCB • VOLUME 193 • NUMBER 7 • 2011   1262
Figure 3.  Panx3 promotes the growth of metatarsus ex vivo. (A) Live images of ex vivo metatarsal growth (top) and histology (bottom). (a) Newborn 
mouse metatarsal bones were cultured and infected with Panx3 adenovirus (AdPanx3) or control adenovirus. (b) Metatarsus cultures were incubated with 
the Panx3 peptide for 3 d. Metatarsal bone growth was measured by real-time imaging. AdPanx3 promoted metatarsal bone growth (a), whereas the 
Panx3 peptide inhibited it (b). (B) Relative change in metatarsal length (Ba) or width (Bb) after 3 d in culture compared with day 0. The bone length was 1263 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
measured from edge to edge (A, a, broken red line). The width was measured from side to side (A, a, red line). AdPanx3 promoted the growth of both 
length and width, whereas Panx3 peptide inhibited both. (C) Quantitative RT-PCR. Metatarsus cultures were incubated for 3 d with AdPanx3 or the Panx3 
peptide. AdPanx3 promoted the expression of osteoblast marker genes, osterix, ALP, and Ocn. The Panx3 peptide inhibited this marker gene expression. 
*, P < 0.05; **, P < 0.01. Error bars represent the mean ± SD; n = 3.
 
shPanx3 were transiently transfected into calvarial cells, whereas 
they were stably transfected into C2C12 cells.
Activation mechanism of Panx3 ER  
Ca
2+ channel
Next, we determined whether any differences existed between 
the  activation  mechanisms  of  the  Panx3  and  IP3R  ER  Ca
2+ 
channels  by  using  inhibitors  of  the  IP3R  function  (Vanden 
Abeele et al., 2006). In control undifferentiated C2C12 cells, 
2-APB, an inhibitor of IP3-induced Ca
2+ release (Maruyama 
et al., 1997), completely blocked Ca
2+ release from the IP3R 
channel in control cells (Fig. 5 A, a). In Panx3-overexpressing 
undifferentiated C2C12 cells, 2-APB treatment resulted in a re-
duction in the [Ca
2+]i levels, which closely corresponded to the 
Figure 4.  Panx3 functions as an ER Ca
2+ channel, and activates the CaM and Akt pathways. (A, a and b) Panx3 ER Ca
2+ channel. C2C12 cells stably 
transfected with pEF1 (black) or pEF1/Panx3 (red) expression vectors were analyzed for ATP-stimulated [Ca
2+]i in a time course (A, a). Primary calvarial 
cells were transiently transfected with pEF1 (black) or pEF1/Panx3 (red) expression vectors (A, b). The data shown are representative of at least four differ-
ent experiments. (A, c) [Ca
2+]i levels during differentiation of C2C12 cells. Untransfected and stably transfected cells with pEF1/Panx3 or shPanx3 vectors 
were cultured with BMP2 at the indicated days. [Ca
2+]i levels in pEF1/Panx3-transfected cells were much higher than in C2C12 cells, whereas those in 
shPanx3 cells were lower. *, P < 0.05; **, P < 0.01. Error bars represent the mean ± SD, n = 3. (B and C) Panx3 activates the CaM/NFATc1 signaling 
pathways. C2C12 cells or primary calvarial cells were stably and transiently transfected with pEF1 and pEF1/Panx3 vectors, respectively, then incubated 
for 1 h with BMP2, and the levels of the signal molecules were analyzed by Western blotting. For shPanx3 inhibition experiments, stably transfected C2C12 
cells or transiently transfected primary calvarial cells with sh control and shPanx3 RNA were cultured for 1 d in the presence of BMP2.JCB • VOLUME 193 • NUMBER 7 • 2011   1264
Figure 5.  Panx3 ER Ca
2+ channel activation and its downstream signaling. C2C12 cells stably transfected with pEF1 or pEF1/Panx3 expression vectors 
were analyzed for ATP-stimulated [Ca
2+]i. Inhibitors were added to the cell culture for 30 min before ATP stimulation. In inhibition to endogenous IP3R3 
expression, [Ca
2+]i was analyzed after 3 d of transfection of C2C12 cells with siRNA for IP3R3. (A) Panx3 ER Ca
2+ channel independent of the IP3R ER 1265 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
Pardali et al., 2005). PPADS inhibited phosphorylation of   
CaMKII induced by Panx3 overexpression (Fig. 5 C, a). Without 
BMP2 treatment, Panx3 overexpression resulted in activation of 
Smad1/5 (Fig. 5 C, b, left). BMP2 induced phosphorylation of 
Smad1/5 in control cells, and Panx3 overexpression further in-
creased phosphorylation levels of Smad1/5 (Fig. 5 C, b, middle), 
whereas this stimulation was blocked by PPADS (Fig. 5 C, b, 
right). These results suggest that the activation of specific P2Rs 
may be involved in Panx3-mediated signaling for osteoblast dif-
ferentiation through CaMKII and Smad1/5 pathways.
Panx3 activates the Akt pathway
In addition to P2R-mediated activation of the PLC–PIP2– 
IP3–IP3R pathway, P2Rs also activate PI3K signaling. Because 
Akt downstream from PI3K is crucial for osteoblast differen-
tiation (Fujita et al., 2004; Mukherjee and Rotwein, 2009), we 
explored the involvement of Akt in Panx3-promoted osteoblast 
differentiation. We found that Panx3 overexpression increased 
phosphorylation of Akt and Akt-downstream MDM2, and pro-
moted the degradation of p53 in both C2C12 and calvarial cells 
(Fig. 6 A, a and b). p53 is a negative regulator of osteogenesis 
(Lengner et al., 2006) and inhibits Runx2 and osterix expres-
sion (Lian et al., 2006). Akt-mediated MDM2 phosphorylation 
leads to p53 ubiquitination (Ogawara et al., 2002). Our results 
indicate that Panx3 expression activates Akt and promotes p53 
degradation through MDM2 activation.
An Akt inhibitor reduced the expression of osterix mRNA 
in control and pEF1/Panx3-transfected C2C12 cells. The domi-
nant-negative Akt vector (Akt DN) also inhibited osterix expres-
sion, whereas the activated Akt vector increased the expression 
(Fig. 6 B, a). Similar results were found for ALP expression 
(Fig. 6 B, b). These results suggest that Panx3 promotes osteo-
blast differentiation in part through the Akt pathway.
Akt activates the Panx3 ER Ca
2+ channel
We next examined the involvement of Akt in the activation of a 
Panx3 ER Ca
2+ channel. We found that the Akt inhibitor abol-
ished ATP-stimulated Panx3 ER Ca
2+ channel activity in Panx3-
overexpressing C2C12 cells (Fig. 7 A, a). The remaining Ca
2+ 
released from the ER was likely through the IP3R ER Ca
2+ chan-
nel, which showed an activity level similar to that in control cells. 
The Akt inhibitor did not inhibit the IP3R ER Ca
2+ channel in 
control cells. Akt DN also inhibited the ATP-stimulated Panx3 
ER Ca
2+ release, but not IP3R ER Ca
2+ release (Fig. 7 A, b). In 
contrast, activated constitutively active Akt (Akt CA) increased 
the activity of the Panx3 ER Ca
2+ channel, but not the activity of 
the IP3R ER Ca
2+ channel (Fig. 7 A, c). In control cells, neither 
[Ca
2+]i levels in control cells (Fig. 5 A, a). This indicates that 
2-APB inhibited the IP3R ER Ca
2+ channel, but not the Panx3 
ER Ca
2+ channel. In control cells, U-73122, a selective inhibitor of 
PLC, which catalyzes DAG and IP3 synthesis (Bleasdale et al., 
1990), completely blocked the IP3R Ca
2+ channel (Fig. 5 A, b); 
however, it only partially inhibited the Panx3 ER Ca
2+ chan-
nel (Fig. 5 A, b). Inhibition of endogenous IP3R3 expression 
by siRNA reduced the IP3R Ca
2+ channel but not the Panx3 
ER Ca
2+ channel (Fig. 5 A, c). Thapsigargin, a highly selective 
inhibitor of the SERCA ER Ca
2+ pumps responsible for loading 
Ca
2+ stores (Inesi and Sagara, 1992), partially inhibited IP3R-
mediated Ca
2+ release from the ER in control cells (Fig. 5 A, d),   
whereas  it  completely  blocked  Ca
2+  release  from  the  ER  in 
Panx3-overexpressing cells (Fig. 5 A, c). This suggests that the 
Panx3 ER Ca
2+ channel continuously released Ca
2+ from the ER 
after thapsigargin treatment. Therefore, the activation mecha-
nism for the Panx3 ER Ca
2+ channel appears to be different 
from that of the IP3R.
Because Panx3 and IP3R ER Ca
2+ channels are both acti-
vated by external ATP, we tested the differences in ATP recep-
tors involved in the activation of these channels. ATP receptors 
(purinergic receptors, P2Rs) consist of two subtypes, the ligand- 
gated cation channels (P2Xs) and the G protein–coupled recep-
tors (P2Ys; Burnstock and Knight, 2004). During osteoblast 
differentiation, a series of P2X and P2Y subtypes are expressed 
(Hoebertz et al., 2000; Orriss et al., 2006; Panupinthu et al., 
2008). To examine whether specific subtypes of P2Rs are re-
quired for the activation of the Panx3 ER Ca
2+ channel, the P2R 
antagonists  pyridoxal-phosphate-6-azophenyl-2,4-disulfonate   
(PPADS) and suramin were tested for their effects on ATP-
stimulated changes in [Ca
2+]i in Panx3-overexpressing and   
control cells (Fig. 5 B). PPADS inhibited Panx3 ER Ca
2+ chan-
nel activity in Panx3-overexpressing C2C12 cells (Fig. 5 B, a), 
whereas it did not inhibit the IP3R Ca
2+ channel in control cells   
(Fig. 5 B, a). Suramin completely inhibited the IP3R Ca
2+ chan-
nel in control cells (Fig. 5 B, b), and partially inhibited the 
Panx3 ER channel in Panx3-overexpressing cells (Fig. 5 B, b).   
A combination of PPADS and suramin completely inhibited 
both Panx3 and IP3R ER channels (Fig. 5 B, c). These results 
indicated that the Panx3 ER Ca
2+ channel is activated through 
PPADS-sensitive P2Rs that are distinct from the IP3R channel.
Because PPADS specifically inhibited the Panx3 ER Ca
2+ 
channel, we tested whether it would also inhibit Panx3-medi-
ated CaM activation. For these experiments, we treated control 
and Panx3 overexpressing C2C12 cells with BMP-2 for 1 h and 
then analyzed the phosphorylation of CaMKII and Smad1/5, 
both of which are targets of CaM (Fig. 5 C; Wicks et al., 2000; 
Ca
2+ channel. 2-APB (IP3R inhibitor; a) or U-73122 (IP3 synthesis inhibitor; b) completely inhibited Ca
2+ release from the IP3R ER Ca
2+ channel. The Panx3 
ER Ca
2+ channel was inhibited by 2-APB (a), whereas it was partially inhibited by U-73122 (b). siRNA for IP3R3 inhibited the IP3R3 ER Ca
2+ channel, but 
not the Panx3 ER Ca
2+ channel (c). Thapsigargin (SERCA ER Ca
2+ pump inhibitor) completely inhibited Ca
2+ release from the ER in pEF1/Panx3-transfected 
cells, whereas it partially inhibited it in pEF1-transfected cells (d). The data shown are representative of at least three different experiments. (B) PPADS 
inhibited the Panx3 ER Ca
2+ channel but not the IP3R ER Ca
2+ channel (a). Suramin completely inhibited the IP3R ER Ca
2+ channel but partially inhibited the 
Panx3 ER Ca
2+ channel (b). A combination of PPADS and suramin blocked both ER Ca
2+ channels (c). Arrows indicate the time of ATP addition. The data 
shown are representative of at least three different experiments. (C) PPADS inhibition of CaM downstream signaling. Stably transfected C2C12 cells with 
pEF1 and pEF1/Panx3 vectors were incubated for 1 h with BMP2, with or without PPADS, and levels of phosphorylation of CaMKII (a) and Smad1/5 (b) 
phosphorylation were analyzed by Western blotting. The left panel in b indicates Smad1/5 phosphorylation levels in cells without BMP2 and PPADS. In 
the middle and right panels of b, cells were induced by BMP2.
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Akt vector affected the IP3R ER Ca
2+ channel (Fig. 7 A, b and c). 
LY294002, an inhibitor of PI3K, inhibited both Panx3 and IP3R 
ER channels (Fig. 7 A, d). The reason for this was that PI3K ac-
tivates Akt as well as the IP3 synthesis pathway (Carpenter and 
Cantley, 1996). These results suggest that ATP-stimulated activa-
tion of the Panx3 ER Ca
2+ channel is mediated through a PI3K–
Akt activation that is distinct from the IP3-dependent activation 
of IP3R ER Ca
2+ channels.
To  further  confirm  the Akt-mediated  activation  of  the 
Panx3 ER Ca
2+ channel, the [Ca
2+]i concentration was measured 
without ATP stimulation (Fig. 7 B). The steady-state [Ca
2+]i  
concentration  in  Panx3-overexpressing  C2C12  cells  was   
140 nM, which was higher than that of control cells (90 nM). 
The activated Akt enhanced the [Ca
2+]i concentration in Panx3-
overexpressing C2C12 cells by about twofold (280 nM) compared 
with that in cells without the Akt vector. Akt DN reduced the 
steady-state [Ca
2+]i concentration in Panx3-overexpressing C2C12 
cells to a level similar to that seen in the control cells. These results 
indicated that the Panx3 ER Ca
2+ channel is regulated by Akt sig-
naling, and that its mechanism is independent of IP3R activity.
We further examined whether Akt-mediated Panx3 ER Ca
2+ 
channel activation regulates the CaM–CaMKII–NFATc1 signal-
ing pathways (Fig. 7 C). Panx3-overexpressing C2C12 cells were 
transfected with the Akt CA or Akt DN vector and were treated 
with BMP2 for 1 h. Western blotting analysis showed that Akt   
CA increased phosphorylation of CaMKII (P-CaMKII) and   
activation of NFATc1 (reduced P-NFATc1), whereas Akt DN in-
hibited CaMKII and NFATc1 activation (Fig. 7 C). These results 
support the notion that the Akt signaling pathway regulates the 
Panx3 ER Ca
2+ channel.
Panx3 releases intracellular ATP through 
its hemichannel activity
The activation of P2Rs may be caused in part by binding of ATP 
released from cells through Panx3 hemichannel activity. To test 
this possibility, we first analyzed the intracellular ATP levels in 
control and Panx3-overexpressing C2C12 cells by fluorescence 
imaging using confocal microscopy (Fig. 8 A, a). The cells 
containing caged luciferin were illuminated by a flash of two-
photon light, which photolyzed the caged luciferin, allowing 
the uncaged luciferin to bind to intracellular ATP and resulting 
in an increase in fluorescence emissions. The fluorescence in-
tensity at 5 and 15 s after photolysis was much higher (red) in 
control C2C12 cells than in Panx3-overexpressing cells, which 
suggests that Panx3 expression reduced intracellular ATP lev-
els. To analyze ATP release, control and Panx3-overexpressing 
C2C12 and calvarial cells were incubated in the presence of 
luciferin for 2 min, and the fluorescence intensity was mea-
sured (Fig. 8 A, b and c). The extracellular ATP level was ap-
proximately twofold higher in Panx3-expressing cells than in 
control cells. Similar results were obtained when the cells were 
treated with KGlu to depolarize the cell membrane, except that 
the level of ATP release was much higher. Addition of anti-
Panx3 antibody, but not IgG, to the cell culture assay inhibited 
Panx3-mediated ATP release (Fig. 8 B, a). To test whether this 
inhibition was specific to Panx3, we used the inhibitory Panx3 
peptide from the extracellular domain of Panx3, which had been 
used as an antigen for the Panx3 antibody (Iwamoto et al., 2010). 
The peptide, but not a scrambled peptide, blocked the inhibitory 
activity of the antibody for the ATP release in a dose-dependent 
manner (Fig. 8 B, a). In addition, the Panx3 peptide alone showed 
inhibitory activity for the ATP release, as described previously in 
chondrogenic ATDC5 cells (Iwamoto et al., 2010). Under dif-
ferentiation  conditions,  suppression  of  endogenous  Panx3  by 
shRNA inhibited ATP release in C2C12 cells (Fig. 8 B, b). These 
results indicated that Panx3 caused the release of intracellular 
ATP into the extracellular space though the hemichannel.
To test the effects of the Panx3 hemichannel on osteoblast 
differentiation, control and Panx3-overexpressing C2C12 cells 
were induced to differentiate by a 2-d treatment with BMP2, in 
the presence or absence of the anti-Panx3 antibody, and mRNA 
levels for osterix and ALP were analyzed (Fig. 8 C). The Panx3 
antibody inhibited the induction of osterix and ALP expression 
Figure 6.  Panx3 activates the Akt pathway. (A, a and b) Panx3 activates 
Akt signaling. Stably transfected C2C12 cells or transiently transfected pri-
mary calvarial cells with pEF1 and pEF1/Panx3 vectors were incubated for 
1 h with BMP2, and levels of signal molecules were analyzed by Western 
blotting. Panx3 expression increased phosphorylation of Akt and MDM2   
and  promoted  p53  degradation.  (B)  Akt  inhibition  reduced  Panx3- 
promoted expression of osterix (a) and ALP expression (b). The transfected 
cells were cultured with BMP2 for 3 d, and the expression of osterix and ALP 
was analyzed by real-time PCR. The Akt inhibitor and Akt DN inhibited the 
expression of Panx3-mediated induction of these genes, whereas Akt CA 
increased the expression levels in control and Panx3-overexpressing cells. 
*, P < 0.05; **, P < 0.01. Error bars indicate the mean ± SD; n = 3.1267 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
networks.  This  Ca
2+  wave  propagation  is  mediated  by  gap 
junctions and promotes cell–cell communication for cellular 
processes and differentiation (Barbe et al., 2006). Therefore, 
we examined Panx3 gap junction activity in C2C12 cells and 
its effect on osteoblast differentiation (Fig. 9). First, Ca
2+ wave 
propagation in Panx3-overexpressing C2C12 cells was ana-
lyzed and compared with that in control cells. The cells were 
loaded with a photosensitive caged form of Ca
2+ and Ca
2+-
sensitive Fluo-4. While performing live-cell Ca
2+ imaging, a 
in both control and Panx3-overexpressing cells. Because the   
antibody and peptide blocked the Panx3 hemichannel activity, 
these results suggest that the Panx3 hemichannel plays a critical 
role in osteoblast differentiation.
Panx3 gap junction function during 
osteoblast differentiation
An increase in [Ca
2+]i in one cell can be transmitted to neigh-
boring cells, resulting in Ca
2+ waves that spread within cell 
Figure 7.  Activation of Panx3 ER Ca
2+ channel by PI3K–Akt signaling. (A) pEF1- or pEF1/Panx3-transfected C2C12 cells were incubated with the Akt 
inhibitor (a), or transfected with the dominant-negative Akt (Akt DN; b), the activated Akt (Akt CA) vector (c), or LY294002 (PI3K inhibitor; d). [Ca
2+]i was 
measured by the fluorescence intensity ratio of Fura-2 (F340nm/F380nm) in each condition. The Akt inhibitor blocked the Panx3 ER Ca
2+ channel (a). Akt DN 
inhibited the Panx3 ER Ca
2+ channel, not the IP3R ER channel (b). Akt CA promoted the Panx3 ER Ca
2+ channel, not the IP3R ER channel (c). LY294002 
inhibited Ca
2+ release from both Panx3 and IP3R ER Ca
2+ channels (d). Arrows indicate the time of ATP addition. The data shown are representative 
of at least three different experiments. (B) The [Ca
2+]i level was increased by Akt activation. The basal levels of [Ca
2+]i in Panx3-overexpressing C2C12 
(pEF1/Panx3) cells are higher than in control vector–transfected (pEF1) cells. Akt CA increased [Ca
2+]i in pEF1/Panx3 cells, whereas Akt DN reduced 
[Ca
2+]i to similar levels in control cells. (C) The transfected cells were induced by BMP2 for 1 h, and phosphorylation of CaMKII and NFATc1 was analyzed 
by Western blotting. Akt increased CaMKII and NFATc1 phosphorylation levels in control cells, and Panx3 overexpression further enhanced its activation.   
Akt DN inhibited these activations to the levels in control cells. *, P < 0.05; **, P < 0.01. Error bars indicate the mean ± SD; n = 3.JCB • VOLUME 193 • NUMBER 7 • 2011   1268
Figure 8.  Panx3 hemichannel releases intracellular ATP and promotes differentiation. (A) Imaging of intracellular ATP levels in pEF1- or pEF1/Panx3-
transfected C2C12 cells. Cells were incubated with the caged luciferin, and then exposed to a flash of UV light for photolysis to convert active luciferin. 
Fluorescence excitation images (red) caused by luciferin–ATP interactions at 5 s and 15 s after a UV flash were shown. Higher red fluorescence images 
were observed in control pEF1-transfected cells compared with Panx3-overexpressing cells, which indicates that Panx3 overexpression reduced intracel-
lular ATP levels. (A, b and c) Measurement of ATP release. The transfected C2C12 cells or primary calvarial cells were treated with or without KGlu for 
2 min, and then ATP released into the media was measured. (B) Inhibition of ATP release. The transfected cells were incubated with Panx3 antibody or 
Panx3 peptide for 30 min, and ATP release was measured. The Panx3 antibody (1.5 µg/ml) inhibited ATP release in pEF1/Panx3-transfected cells (a). 
This inhibition was blocked by various concentrations of the Panx3 peptide. The Panx3 peptide also inhibited the ATP release (a). Control sh- or shPanx3- 
transfected cells were cultured with BMP2 for 2 d, and ATP release was measured. ATP release was reduced in shPanx3-transfected cells compared with 
control sh-transfected cells (b). (C) Inhibition of osterix (a) and ALP (b) expression by the anti-Panx3 antibody. *, P < 0.05; **, P < 0.01. Error bars represent 
the mean ± SD; n = 3.1269 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
Figure 9.  Panx3 functions as a gap junction. (A) Real-time imaging of Ca
2+ wave propagation. The Ca
2+ wave was measured in cells loaded with Fluo-4 
and NP-EGTA (caged Ca
2+) by starting photolysis of NP-EGTA in a single cell using a flash of UV light. (a) pEF1/Panx3-transfected cells, but not pEF1-
transfected cells, propagated Ca
2+ waves to neighboring cells. (b) Inhibition of the Ca
2+ wave propagation by CBX (gap junction inhibitor). (c) Apyrase, 
ATP receptor antagonist, did not inhibit Ca
2+ propagation in pEF1/Panx3-transfected cells. (B) CBX inhibited C2C12 cell differentiation. (a) ALP staining. 
(b) Quantitative data from the ALP staining. CBX inhibited osteoblast differentiation in pEF1/Panx3-transfected cells (a and b). *, P < 0.05; **, P < 0.01. 
Error bars represent the mean ± SD; n = 3.JCB • VOLUME 193 • NUMBER 7 • 2011   1270
single cell within a cell network was subjected to two-photon 
photolysis. The uncaged Ca
2+ fluctuations were analyzed by 
live-cell fluorescence confocal microscopy (Fig. 9 A, a; and 
Videos 5 and 6). We also observed similar Ca
2+ wave propaga-
tion in Panx3-overexpressing calvarial cells (unpublished data). 
In  Panx3-overexpressing  cells,  Ca
2+  waves  were  propagated 
into neighboring cells (red in high Ca
2+), whereas in control 
cells  lacking  Panx3,  the  Ca
2+  fluctuations  were  restricted  to   
the  single  uncaged  cell.  This  Ca
2+  wave  propagation  was 
inhibited by the gap junction inhibitor carbenoxolone (CBX;   
Fig. 9 A, b; and Videos 7 and 8). Because CBX may disrupt 
the cell membrane and affect activation of P2 receptors, thereby 
inhibiting the Ca
2+ wave, apyrase (an ATP receptor antagonist) 
was added to the Ca
2+ wave assay at a concentration, which in-
hibited Panx3-mediated activation of Akt signaling (Fig. S3). 
We found that apyrase did not inhibit the Ca
2+ wave, which sug-
gests that Panx3 gap junction mediates Ca
2+ wave propagation 
(Fig. 9 A, c; and Videos 9 and 10). To test the effect of Panx3-
mediated gap junction activity on C2C12 cell differentiation, 
Panx3-overexpressing and control cells were induced to dif-
ferentiate by BMP2 treatment in the presence of CBX, and 
ALP activity was measured (Fig. 9 B). Panx3 overexpression 
promoted ALP activity, as shown in Fig. 2, but CBX inhibited 
this ALP activation. Similarly, Panx3 shRNA inhibited ALP 
induction, as shown in Fig. 2, and CBX further inhibited ALP 
activity. These results indicated that Panx3 can function as a 
gap junction and propagate Ca
2+ waves from cell to cell, and 
that this activity also promotes osteoblast differentiation.
Discussion
In our present study, we demonstrated for the first time that 
Panx3 regulates osteoblast differentiation through its multiple 
functions as a hemichannel, an ER Ca
2+ channel, and a gap 
junction, as illustrated in Fig. 10. All three Panx3 activities are 
associated with and involved in osteoblast differentiation. We 
showed that Panx3 is induced during osteogenic differentiation 
and is localized in the plasma membrane, and that it functions 
as  the  hemichannel  that  releases ATP  into  the  extracellular 
space. The ATP released from the cells binds to purinergic re-
ceptors (P2Rs) in the plasma membrane in an autocrine and 
paracrine manner, and thereby activates P2R–PI3K–Akt signal-
ing  for  the  Panx3  channel  and  P2R–PLC–PIP2–IP3  for  the 
IP3R channel. Akt-mediated Panx3 ER Ca
2+ channel activation 
induces Ca
2+ release from the ER into the cytosol, which subse-
quently activates CaM signaling pathways, including CaMKII–
Smad, CaMKII–c-Fos, and CN–NFATc. The Akt activation also 
increases p53 degradation through activation of MDM2. The 
activation of these pathways promotes differentiation. In addi-
tion, the increased [Ca
2+]i level that originated in cells because 
of the hemichannel in turn propagates its wave into surrounding 
cells through a Panx3 gap junction, subsequently promoting 
Ca
2+  signaling  among  cell  populations  for  differentiation.   
Because blocking of the Panx3 hemichannel inhibits osteoblast 
differentiation, this hemichannel activation may be the first step 
in Panx3-mediated differentiation processes.
Ca
2+ is one of the most important second messengers 
and regulates many cellular processes (Berridge et al., 2000b), 
and the CaM pathway is critical for osteoblast differentiation   
(Zayzafoon,  2006).  However,  the  mechanism  for  controlling 
[Ca
2+]i during osteoblast differentiation is not yet clear. We found 
that Panx3 functions as a Ca
2+ channel in the ER, through which it 
regulates [Ca
2+]i. C2C12 and calvarial cells express IP3Rs. Both 
Panx3 and IP3Rs function as ER Ca
2+ channels; however, their 
activation mechanisms are different. We found that the Panx3 
ER Ca
2+ channel was activated through Akt signaling (Fig. 7 A), 
distinct from IP3-mediated activation of ubiquitous IP3R ER 
Ca
2+ channels (Mikoshiba, 2007). In addition, siRNA for IP3R3 
and 2-APB, which is an inhibitor of IP3R-mediated Ca
2+ release, 
inhibited IP3R ER Ca
2+ channel activity, but did not inhibit the 
Panx3 channel (Fig. 5 A). The role of IP3Rs in osteogenic dif-
ferentiation is also not yet clear. The inhibition of endogenous 
Panx3 by shRNA resulted in substantial inhibition of osteogenic 
differentiation in C2C12 cells, despite IP3R expression, whereas 
the inhibition of IP3Rs by siRNA and 2-APB showed limited 
inhibition of C2C12 cell differentiation (unpublished data).   
In addition, mice lacking either IP3R2 or IP3R3 were viable 
and had no obvious abnormalities. Mice lacking both IP3R2 
and IP3R3 were born with a normal appearance but began los-
ing body weight after weaning because of defects in exocrine 
secretion (Futatsugi et al., 2005). Both receptors may function 
as ER Ca
2+ channels with distinct activation mechanisms during   
osteogenic differentiation. Because the Panx3 hemichannel 
likely triggers activation of these Panx3 and IP3R ER Ca
2+ chan-
nels, Panx3 may play a major role upstream of IP3Rs in osteo-
genic differentiation.
Figure  10.  Panx3  pathways  in  osteoblast  differentiation.  The 
Panx3  hemichannel  releases  intracellular  ATP.  The  released  ATP 
binds to purinoreceptors (P2Rs) in its own cell and/or neighbor-
ing cells, and activates the PI3K–Akt pathway. Akt then activates 
the Panx3 ER Ca
2+ channel to increase [Ca
2+]i levels, which leads 
to activation of the CaM–CaMKII pathway. The ATP also activates 
the PLC–PIP2–IP3R ER Ca
2+ channel pathway, which is distinct from 
that of the Panx3 ER Ca
2+ channel. The Akt activation also phos-
phorylates MDM2, which induces degradation of p53, an inhibitor 
for osteogenic differentiation, and promotes differentiation. CaM 
also  activates  CN,  which  dephosphorylates  inactive  phosphory-
lated NFAT in cytosol. Dephosphorylated NFATc1 enters the nucleus 
and binds to the promoter regions of differentiation genes such as 
osterix and ALP. Activated CaMKII also increases c-fos and NFAT 
expression, and activation of Ap-1 and Smad1/5. Panx3 gap junc-
tion activity promotes Ca
2+ wave propagation between adjacent 
cells for differentiation.1271 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
(Lecanda et al., 2000). Mice with conditional Cx43 deletion in 
osteoblasts displayed a normal appearance at birth but devel-
oped a low bone density osteopenia phenotype with age (Chung   
et al., 2006). Panx3 overexpression in differentiated C2C12 cells 
promoted Cx43 expression, whereas suppression of endogenous 
Panx3 by Panx3 shRNA inhibited Cx43 expression (unpublished 
data). These results suggest that Panx3 and Cx43 may play dis-
tinct roles in osteogenic differentiation.
In summary, we have provided evidence that Panx3 acts 
as a multifunctional protein that promotes osteoblast differenti-
ation by regulating Akt and Ca
2+ signaling through its hemi-
channel, ER channel, and gap junction activities.
Materials and methods
Reagents
Rabbit  anti-Panx3  antibody,  inhibitory  Panx3  and  scrambled  peptides, 
Panx3 expression vector (pEF1/Panx3) and control vector (pEF1), shRNA 
vector for Panx3 (shPanx3), and control vector (sh control) have been de-
scribed previously (Iwamoto et al., 2010). In brief, the pEF1/Panx3 vector 
was constructed by cloning the coding sequence of mouse Panx3 cDNA 
into the pEF1/V5-His vector (Invitrogen). The shPanx3 vector containing 
the 3 untranslated region of Panx3 (5-GGCAGGGTAGAACAATTTA-3) 
in a pSM2 vector was obtained from Thermo Fisher Scientific. A rabbit 
polyclonal antibody to a peptide (amino acid residues HHTQDKAGQYKVK-
SLWPH) from the mouse Panx3 protein was generated and purified with a 
peptide affinity column. This Panx3 peptide was also used for inhibition ex-
periments. A peptide with a scrambled sequence (WHTKYQVGLDPQH-
KASHK) of the Panx3 peptide was used as a control. Control adenovirus 
(Ad-Cont) and Panx3 expression adenovirus (Ad-Panx3) were prepared 
and purified by Welgen, Inc. Akt CA and Akt DN vectors were obtained 
from Addgene. Antibodies for P-Rb, CaM, CaMKII, P-CaMKII, CN, p53, 
Akt, p-Akt, Smad1, and P-Smad1/5 were obtained from Cell Signaling 
Technology; Rb, P-NFATc1, and MDM2 were from Santa Cruz Biotechnol-
ogy, Inc.; NFATc1 was from BD; -tubulin from Sigma-Aldrich; Ocn from 
Biomedical Technology; and calnexin from Thermo Fisher Scientific. 2-APB, 
U-73122,  thapsigargin,  PPADS,  suramin,  CBX,  and  apyrase  were  ob-
tained from Sigma-Aldrich; Akt inhibitor was from EMD; LY294002 and 
Fura-2AM were from Invitrogen; BMP2 was from Humanzyme; and iQ 
SYBR  Green  Supermix  was  from  Bio-Rad  Laboratories.  HRP-conjugated 
goat anti–mouse and goat anti–rabbit IgG were obtained from United 
States Biological.
Cell culture
Mouse C2C12 cells were grown in DME (Invitrogen) containing 10% FBS 
(HyClone)  at  37°C  under  5%  CO2.  For  osteoblast  differentiation,  cells 
(90% confluence) were transiently or stably transfected with pEF1/Panx3, 
control vector, Panx3 shRNA, or sh control vector and cultured in the pres-
ence of 300 ng/ml BMP2 (Humanzyme) and 2% FBS. The media were 
replaced every 3 d. Primary calvarial cells were prepared from calvaria of 
newborn mice as described previously (Matsunobu et al., 2009). Calvaria 
were digested six times for 10 min with 0.1% collagenase type 1 (Worthing-
ton Biochemical Corp.) and 0.2% dispase II (Roche) in PBS. The last two 
fractions were centrifuged at 1,500 rpm for 5 min, resuspended in culture 
medium consisting of -minimum essential medium (Invitrogen) with 10% 
FBS (HyClone), 100 U/ml of penicillin, and 100 µg/ml of streptomycin. Pri-
mary calvarial cells were transiently transfected with Nucleofector (Lonza). 
For the differentiation assay, primary calvarial cells were induced by the 
addition of 50 µg/ml ascorbic acid (Sigma-Aldrich) and 5 mM -glycero-
phosphate (Sigma-Aldrich).
Immunostaining
Growth plates of newborn mice were fixed overnight in 4% paraformal-
dehyde and dehydrated before they were embedded in paraffin. After 
deparaffinization  and  rehydration,  sections  were  digested  with  pepsin 
(Biocare Medical), blocked by Rodent block (Biocare Medical), and then   
reacted with primary antibodies for 2 h at room temperature. In cell culture, 
C2C12 cells were blocked by Power block (Biocare Medical) and reacted 
with primary antibodies under the same condition as described in the   
Cell culture section. Primary antibodies were detected by Alexa Fluor 488 
(Invitrogen)- or Cy-3 (Jackson ImmunoResearch Laboratories)-conjugated   
Extracellular ATP modulates cellular functions by binding 
in autocrine and paracrine manners to two subtypes, P2XR1-7 and 
P2YR1-12, of a large family of purinergic receptors (Corriden and 
Insel, 2010). P2YRs are G protein–coupled receptors that acti-
vate signaling pathways responsible for releasing Ca
2+ from the 
ER, whereas P2XRs are nonselective cation channels that per-
meabilize Ca
2+, Na
+, and other cations (Burnstock and Knight, 
2004). During osteoblast differentiation, many P2X and P2Y 
members are expressed and implicated in bone formation   
(Hoebertz et al., 2000; Orriss et al., 2006; Panupinthu et al., 
2008). Both Panx3 and IP3R ER Ca
2+ channels were activated by 
ATP (Fig. 4). PPADS and suramin function to commonly inhibit 
some P2Ys and P2XRs (e.g., P2X1, P2X3, and P2Y6); however, 
they also inhibit specifically (e.g., PPADS for P2Y1 and P2Y4; 
suramin for P2X2, P2X5, and P2Y2; P2 receptors; Burnstock, 
2007). Panx3 ER Ca
2+ channels, but not IP3R ER Ca
2+ channels, 
were inhibited by PPADS (Boyer et al., 1994; Ziganshin et al., 
1994), whereas suramin inhibited both channels (Fig. 5 B). These 
results suggest that the Panx3 and IP3R ER Ca
2+ channels may 
be regulated through different purinergic receptors. The ATP- 
induced [Ca
2+]i experiments were performed in cell culture with-
out external Ca
2+ in the medium to measure [Ca
2+]i released from 
the ER. However, in vivo, external Ca
2+ may also contribute to an 
increase in [Ca
2+]i through the ATP-P2X cation channels. Indeed, 
P2X7 knockout mice displayed reduced periosteal bone forma-
tion and response to mechanical loading (Ke et al., 2003; Li   
et al., 2005).
Panx3  expression  increased  phosphorylation  of  Akt   
(Fig. 6 A). Akt signaling is required for osteoblast differentia-
tion, bone formation, and prevention of osteoblast apoptosis 
(Kawamura et al., 2007; Mukherjee and Rotwein, 2009). One 
of the Akt target pathways is the MDM2/p53 signaling path-
way (Lengner et al., 2006; Wang et al., 2006). Panx3 expres-
sion promoted phosphorylation of MDM2 and enhanced the 
degradation of the p53 protein (Fig. 6 A). These results indi-
cate that Panx3-promoted osteogenic differentiation occurs in 
part due to reduction of the p53 level through enhancement of 
the Akt–MDM2–p53 pathway (Fig. 10). We found that Panx3 
also stimulated phosphorylation of Smad1/5 (Fig. 5 C). Previ-
ous studies have shown that CaM–CaMKII activates Smad1/5 
(Scherer and Graff, 2000), and therefore, Panx3 ER Ca
2+ chan-
nel/CaM–CaMKII signaling activates Smad1/5. The anti-Panx3 
antibody and PPADS inhibited the Panx3-promoted Smad1/5 
activation,  which  suggests  that  the  Panx3  hemichannel  and 
P2Rs are involved in these processes.
Panx1 and Panx2 were expressed in C2C12 and primary 
calvarial cells at a very low level and were not induced at all 
during  osteogenic  differentiation  of  these  cells  (unpublished 
data). Therefore, Panx3 is the major pannexin protein expressed 
during osteoblast differentiation. Among the connexin gap junc-
tion proteins, Cx43 is the most highly expressed in osteoblasts 
(Civitelli et al., 1993; Su et al., 1997; Gramsch et al., 2001; 
Jiang et al., 2007), and is implicated in osteoblast differentiation 
and mineralization (Lecanda et al., 2000; Stains and Civitelli, 
2005; Chung et al., 2006; Inose et al., 2009). Cx43 knockout 
mice  showed  cranial  abnormalities  and  delayed  ossification, 
whereas axial and appendicular elements were normal at birth JCB • VOLUME 193 • NUMBER 7 • 2011   1272
secondary antibodies. Nuclear staining was performed with Hoechst dye 
(Sigma-Aldrich). Analysis was performed on an inverted confocal microscope 
(LSM 510) and a fluorescence microscope (Axiovert 200; both from Carl 
Zeiss). Colocalization was analyzed by MetaMorph (Molecular Devices).
RT-PCR
Total  RNA  was  extracted  using  the  Nuclear  Extraction  System  Quick-
Gene-810 and HC kit S (Fujifilm). Total RNA (1 µg) was used for reverse 
transcription to generate cDNA, which was used as a template for PCRs 
with gene-specific primers (Table S1), as described previously (Iwamoto   
et al., 2010). The cDNA was amplified with an initial denaturation at 
95°C for 3 min; then 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s 
for 30 cycles; and then amplified with a final elongation step at 72°C for   
5 min before being separated on agarose gels. Real-time PCR amplifi-
cation was performed with iQ SYBR Green Supermix (Bio-Rad Laborato-
ries) and a Chromo4 thermocycler (Bio-Rad Laboratories). Real-time PCR 
was performed for 40 cycles at 95°C for 1 min, 60°C for 1 min, and 
72°C for 1 min. Gene expression was normalized to the housekeeping 
gene Hprt.
ATP flux
ATP flux was determined by luminometry, as described previously (Iwamoto 
et al., 2010). To open the pannexin channels, the cells were depolarized 
by incubation in KGlu solution (140 mM KGlu, 10 mM KCl, and 5.0 mM 
TES, pH 7.5) for 10 min. The supernatant was collected and assayed with 
luciferase/luciferin (Promega). The luminescence was measured using a 
multimode plate reader, Mithras LB 940 (Berthold). For inhibition by the 
Panx3-antibody, the cells were incubated with 1.5 ng/ml affinity-purified 
antibody or control IgG for 30 min before assay.
Western blot analysis
The cells were washed three times with PBS containing 1 mM sodium vana-
date (Na3VO4), then solubilized in 100 µl of lysis buffer (10 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 10 mM MgCl2, 0.5% Nonidet P-40, 1 mM phenyl-
methylsulfonyl fluoride, and 20 U/ml aprotinin). Lysed cells were centri-
fuged at 14,000 rpm for 30 min, and the protein concentration of each 
sample was measured with Micro-BCA Assay Reagent (Thermo Fisher Sci-
entific). A 10 µg sample of each protein was electrophoresed in 4–12% 
SDS-polyacrylamide gel (Invitrogen) and transferred onto a polyvinylidene 
difluoride membrane using iBlot (Invitrogen). The membranes were immuno-
blotted with antibodies using standard protocols.
ALP assay
C2C12 cells and primary calvarial cells were plated into 12- or 96-well 
culture plates and grown to 100% confluence. The cells were then induced 
to differentiate into osteoblasts by addition of 300 ng/ml BMP2. ALP activ-
ity was measured in cell layers using a p-nitrophenyl phosphate substrate 
and an incubation temperature of 37°C, or was determined by the tartrate-
resistant acid phosphatase (TRACP) & ALP double-stain kit (Takara Bio Inc.). 
The  protein  concentration  was  determined  by  the  BCA  protein  assay 
method (Thermo Fisher Scientific).
Alizarin red S staining
C2C12 cells were fixed with 60% isopropanol and stained with 1% (wt/vol)   
Alizarin red S (Sigma-Aldrich). Calcium deposition was quantified as previ-
ously described (Mukherjee and Rotwein, 2009). In brief, the cultures were 
extracted from the Alizarin red S stain with 10% cetylpyridinium chloride 
(Sigma-Aldrich), and the OD was measured at 550 nm.
Ex vivo metatarsal bone culture
Metatarsal bones were isolated from newborn C57BL/6 mice and were 
cultured  in  DME  containing  0.5%  bovine  serum  albumin,  50  µg/ml 
ascorbic acid (Sigma-Aldrich), and 1 mM -glycerol phosphate (Sigma-
Aldrich) at 37°C in a humidified atmosphere of 5% CO2, as described 
previously (Mukherjee and Rotwein, 2009). One day after starting the 
culture, the metatarsal bones were infected with Ad-Cont or Ad-Panx3   
(1 × 10
9 PFU/ml) for 3 d. For the peptide inhibition assay, Panx3 antigen 
peptide or a scramble peptide (100 µg/ml) was added to the metatarsal 
cultures and incubated for 3 d. Live images were captured with a cam-
era (Infinity2; Lumenera) attached to a microscope (Axiovert 25; Karl 
Zeiss). Images were analyzed and adjusted using MetaMorph (Molecular   
Devices) and National Institutes of Health ImageJ software. Metatarsals 
were fixed in 4% paraformaldehyde overnight at 4°C and stored in 70% 
ethanol. Bones were embedded in paraffin blocks and sectioned. Sec-
tions were stained with hematoxylin and eosin. Images were captured 
with microscope camera (AxioCam; Carl Zeiss) attached to a microscope 
(Axiovert 135; Carl Zeiss).
[Ca
2+]i measurements
C2C12 cells were grown in a 96-well plate for 3 d and then loaded with 
5 µM Fura-2AM (Invitrogen) prepared in HBSS for 45 min at 37°C in 5% 
CO2. After 3 d of transfection, transiently transfected primary calvarial cells 
were loaded at the same condition as the C2C12 cells. The Ca
2+ transients 
were recorded as the 340/380 nm ratio (R) of the resulting 510-nm emis-
sions using a plate reader (Mithras LB 940; Berthold Technologies). For 
the stimulation, 200 µM of ATP was automatically injected into cells by the 
Mithras 940. For inhibition experiments, cells were incubated for 30 min 
before analysis with one of the following inhibitors: 5 M U-73122 for IP3 
synthesis inhibition, 100 µM 2-APB for blocking IP3R, 0.5 µM thapsigar-
gin for SERCA ER Ca
2+ pump inactivation, 100 µM PPADS, and 300 µM 
suramin for P2Rs inhibition; 5 µM Akt inhibitor; and 100 µM LY294002 for 
PI3K inhibition. The C2C12 cells that had been stably transfected with either 
pEF1/Panx3 or control vector were then transiently transfected with siIP3R-3 
(Thermo Fisher Scientific). After 3 d of transfection, [Ca
2+]i was measured. 
The [Ca
2+]i levels were calculated as described previously (Grynkiewicz et al., 
1985) using the equation [Ca





where Rmin is the ratio at zero Ca
2+, Rmax is the ratio when Fura-2 is com-
pletely saturated with Ca
2+, F
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max is the fluorescence at saturating Ca
2+ and Kd = 224 nM.
Imaging of single-cell intracellular ATP concentrations and Ca
2+  
wave propagation
For  the  imaging  of  single-cell  intracellular  ATP  levels,  cells  attached  to 
glass-bottomed dishes (MatTek Corporation) were loaded with 25 µM of 
caged d-luciferin AM (Invitrogen) in HBSS containing 10 mM Hepes for 
20 min at room temperature, followed by washing. The cells were then 
incubated with KGlu solution for 10 min. For Ca
2+ wave propagation, cells 
seeded in a glass bottom dish were incubated in HBSS containing 4 µM 
of the Ca
2+ indicator Fluo-4 AM, 10 µM pluronic F-127 (Invitrogen), 0.1% 
OxyFluor (Oxyrase), and 2.5 µM caged reagent NP-EGTA AM (Invitrogen) 
for 30 min at room temperature, followed by washing and incubation 
with Ca
2+-free HBSS. Both luciferin AM and Fluo-AM were imaged using 
a microscope (LSM 510 NLO META) equipped with A-Plan-Apochromat 
63× (1.4 NA) objective lenses (all from Carl Zeiss). A 488 nm argon 
laser line was used for excitation. Cells were imaged every 1 s for 1 min 
after the uncaging step. d-Luciferin AM and NP-EGTA AM were uncaged 
using a two-photon laser set at 730 nm. A nucleus-sized region of interest 
was used for uncaging within single cells using the Zen software’s bleach 
function (Carl Zeiss). To block the gap junction channels, cells were incu-
bated with 25 µM CBX. To inhibit ATP receptors, cells were incubated with   
20 U apyrase.
Focal microscopy images were obtained using a two-photon confocal 
microscope. 488 nm argon, 543 nm HeNe1, and 633 nm HeNe2 lasers were 
used to excite Cy2, Cy3, and Cy5 fluorophores, respectively. The pinholes for 
each laser line were aligned for optimal confocality. For DAPI illumination, the 
two-photon laser was tuned to 730 nm and used at 3–8% power.
Data analysis
Each experiment was repeated several times. The data were analyzed by 
Prism 5 software. Statistical differences between two groups of data were 
analyzed with a Student’s t test. A one-way ANOVA was used for the 
quantification of Alizarin red S staining. P < 0.05 was considered statisti-
cally significant.
Online supplemental material
Fig. S1 shows Panx3 expression levels in the pEF1/Panx3- and shPanx3-
transfected  C2C12  cells,  and  the  protein  expression  levels  for  Panx3, 
IP3R3,  and  RyR3  in  undifferentiated  and  differentiated  C2C12  cells.   
Fig.  S2  shows  the  effects  of  Panx3  expression  or  shPanx3  inhibition 
on  calvarial  cell  differentiation  and  an  increase  in  [Ca
2+]  levels  dur-
ing differentiation of calvarial cells. Fig. S3 shows the inhibition of Akt 
activation  by  apyrase  in  C2C12  cells  transfected  with  pEF1/Panx3.   
Videos 1–4 show imaging of ex vivo metatarsal growth by infection with 
Panx3 adenovirus (AdPanx3) or treatment with the inhibitory Panx3 pep-
tide.  Videos  5–8  show  imaging  of  the  Ca
2+  wave  propagation  in  the 
pEF1/Panx3 transfected C2C12 cells with and without CBX, and Videos 9 
and 10 show no inhibitory effects of apyrase on the Ca
2+ wave propaga-
tion. Table S1 shows the primers used for semi-quantitative and quantita-
tive RT-PCR. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201101050/DC1.1273 Pannexin 3 and osteoblast differentiation • Ishikawa et al.
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